Esomeprazole and omeprazole might boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) bringing about amplified adverse effects including drowsiness, although the medical relevance is reduced in the majority of clients – observe the patient for adverse effects (e.If affected person cannot resume their regular oral medication